$1.15
0.076.48%
At close: -
$1.12
-0.03-2.61%
After Hours: Jan 24, 7:28 PM EDT
TherapeuticsMD reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TherapeuticsMD using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2023-11-14 | $-0.13 | $-0.05 | -160.0 % |
Q2 | 2023-08-14 | $-0.24 | $-0.07 | -242.9 % |
Q1 | 2023-05-15 | $-0.24 | $0.06 | -500.0 % |
Q4 | 2023-04-07 | $-3.62 | $-1.11 | -226.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2023-11-14 | $-53.00K | $500.00K | -110.6 % |
Q2 | 2023-08-14 | $437.00K | $500.00K | -12.6 % |
Q1 | 2023-05-15 | $416.00K | $1.70M | -75.5 % |
Q4 | 2023-04-07 | $1.15M | $23.80M | -95.2 % |
TherapeuticsMD (TXMD) is scheduled to report earnings on March 28, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.05, which missed the estimate of $0.00.
The Actual Revenue was $547K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.